Table 2.
Rehabilitation characteristics of cancer patients in IRFs (UDSMR), October 2010–September 2012 (N=27,952)
| Characteristic | All Patients*,† (N=27,952) | Brain and Nervous System (n=14,780) | Digestive (n=3346) | Bones and Joints (n=2437) | Blood and Lymph (n=2128) | Respiratory (n=1991) | Other‡ (n=3270) |
|---|---|---|---|---|---|---|---|
| Admission FIM total | 65.1±14.1 | 58.9±17.1 | 62.8±15.2 | 64.7±14.4 | 63.1±15.5 | 66.4±14.9 | 63.4±15.5 |
| Motor | 38.1±12.4 | 37.9±13.2 | 37.9±11.3 | 36.9±11.3 | 37.9±11.6 | 41.5±11.3 | 38.8±11.5 |
| Cognitive | 23.1±7.4 | 21.0±7.4 | 24.9±6.3 | 27.8±6.0 | 25.2±6.9 | 24.9±6.1 | 25.1±6.7 |
| Discharge FIM total | 84.7±22.1 | 81.2±23.1 | 89.7±19.4 | 86.9±20.5 | 84.6±21.2 | 91.5±20.0 | 89.6±19.9 |
| Motor | 57.8±17.9 | 56.3±18.7 | 60.8±16.1 | 56.4±17.6 | 56.3±17.2 | 62.7±16.5 | 60.6±16.4 |
| Cognitive | 26.9±6.9 | 24.9±7.2 | 28.9±5.5 | 30.5±5.2 | 28.3±6.4 | 28.8±5.5 | 29.0±5.8 |
| FIM total change | 23.5±16.2 | 22.3±16.3 | 26.9±16.0 | 22.2±15.8 | 21.5±15.5 | 25.1±15.9 | 26.2±15.8 |
| Motor | 19.7±13.6 | 18.4±13.5 | 22.9±13.5 | 19.4±13.5 | 18.4±13.1 | 21.2±13.4 | 22.3±13.3 |
| Cognitive | 3.8±4.9 | 3.9±5.0 | 4.0±5.0 | 2.8±4.9 | 3.1±4.8 | 3.9±4.9 | 3.9±4.8 |
| Rehabilitation length of stay (d) | 12.6±7.4 | 13.2±7.8 | 11.3±5.5 | 13.7±8.3 | 12.7±8.0 | 10.4±5.0 | 11.8±6.2 |
| Length of stay efficiency§ | 2.2±1.9 | 2.1±1.9 | 2.6±2.0 | 2.0±2.0 | 2.0±1.7 | 2.7±2.1 | 2.6±2.0 |
| Discharge to community (%)|| | 72.0 | 72.5 | 73.7 | 70.8 | 62.0 | 75.2 | 75.4 |
| Discharge to acute care (%) | 16.5 | 14.9 | 16.8 | 18.1 | 28.4 | 17.0 | 14.7 |
NOTE. Values are mean ± SD. Cancer patients were identified by ICD codes 140–209.36 and 209.72–209.79.
One-way analysis of variance was used to test the difference in means for continuous variables between cancer subgroups. All P values were P<.001.
Chi-square test of independence was used to test the difference in discharge settings between cancer subgroups. All P values were P<.001.
Other cancers include urinary, genital, soft tissue, oral cavity and pharynx, breast, skin, endocrine, and eye and orbit cancers.
Length of stay efficiency is the discharge FIM change divided by the rehabilitation length of stay (ie, the number of FIM points gained per day).
Community venues include discharges to home, transitional living, board and care, and assisted living.